AxoGen, Inc. provided earnings guidance for the fourth quarter and full year of 2021. Fourth quarter revenue is expected to be approximately $31.5 million, a 3% decrease compared to fourth-quarter 2020 revenue of $32.5 million.

Management now expects 2021 revenue to be approximately $127.3 million and continues to expect full-year 2021.